Skip to main content

MoneyWorks4Me

Lupin informs about press release

01 Dec 2025 Evaluate

Lupin has informed that it enclosed a Press Release titled ‘Lupin Receives Approval from U.S. FDA for Biosimilar Armlupeg™ (Pegfilgrastim-unne).’

The above information is a part of company’s filings submitted to BSE.